These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24935472)

  • 1. SMAD7: a timer of tumor progression targeting TGF-β signaling.
    Luo L; Li N; Lv N; Huang D
    Tumour Biol; 2014 Sep; 35(9):8379-85. PubMed ID: 24935472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on inhibitory SMAD7 in health and disease.
    de Ceuninck van Capelle C; Spit M; Ten Dijke P
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.
    Park SH; Jung EH; Kim GY; Kim BC; Lim JH; Woo CH
    Mol Cells; 2015 Jan; 38(1):20-5. PubMed ID: 25518932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
    Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
    J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad7 suppresses melanoma lung metastasis by impairing Tregs migration to the tumor microenvironment.
    Ma D; Qiao L; Guo B
    Am J Transl Res; 2021; 13(2):719-731. PubMed ID: 33594321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual role of Smad7 in the control of cancer growth and metastasis.
    Stolfi C; Marafini I; De Simone V; Pallone F; Monteleone G
    Int J Mol Sci; 2013 Dec; 14(12):23774-90. PubMed ID: 24317436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad7 inhibits differentiation and mineralization of mouse osteoblastic cells.
    Yano M; Inoue Y; Tobimatsu T; Hendy G; Canaff L; Sugimoto T; Seino S; Kaji H
    Endocr J; 2012; 59(8):653-62. PubMed ID: 22673292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of TGF-beta signaling by Smad7.
    Yan X; Liu Z; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):263-72. PubMed ID: 19352540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Smad7: emerging roles in health and disease.
    Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
    Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.
    Luwor RB; Baradaran B; Taylor LE; Iaria J; Nheu TV; Amiry N; Hovens CM; Wang B; Kaye AH; Zhu HJ
    Oncogene; 2013 May; 32(19):2433-41. PubMed ID: 22751114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus.
    Yan X; Pan J; Xiong W; Cheng M; Sun Y; Zhang S; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):128-36. PubMed ID: 24369345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
    Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
    Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells.
    Landström M; Heldin NE; Bu S; Hermansson A; Itoh S; ten Dijke P; Heldin CH
    Curr Biol; 2000 May; 10(9):535-8. PubMed ID: 10801443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.